Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes

Completed

Brief Summary: The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).

Detailed Description: This is a prospective, observational, multi-center, clinical study examining predictors of clinical outcomes for patients undergoing endovascular treatment of lesions within or extending into the target area (10 cm above the medial epicondyle to the digital arteries). This includes disease in a vessel located within or extending into the distal superficial femoral artery (SFA), popliteal (POP), tibial peroneal trunk (TPT), anterior tibial (AT), posterior tibial (PT), and peroneal tibial (PR) arteries.

Recruitment & Eligibility

Inclusion Criteria

Subject's age ≥ 18 years.
Subject presents with a Rutherford classification of 2 to 6.
Subject presents with clinical evidence of PAD requiring endovascular intervention on one or both limbs that includes a target lesion in a native vessel located within or extending into 10 cm above the medial epicondyle to the digital arteries.
- If subject presents with bilateral disease, the first limb treated with a lesion in the target area will be considered the target limb.
- For subjects with one or more wounds on the target limb, the target lesion(s) should be considered the lesion(s) in the vessel(s) that provide(s) blood flow to the wound(s).
Subject has at least one lesion in a native vessel located within or extending into the target area that is crossed and treated with an endovascular device.

Exclusion Criteria

Subject is unwilling or unable to sign the IRB-approved informed consent form (ICF).
Subject is unable to understand or comply with the study protocol requirements.
Subject is currently participating in an investigational drug or other device study that can clinically interfere with the endpoints of this study.
Subject requires a conversion from endovascular intervention to a surgical bypass graft for any lesion(s) in the target area, as determined by the Investigator.
Subject has an in-stent restenosis in the target area, and this lesion is the only one requiring treatment.
Subject is pregnant or planning to become pregnant within the study period.
Subject has an anticipated life span of less than one (1) year.

Primary Outcome Measures

Name	Time	Method
Procedural Success of Endovascular PAD Treatment(s)	Participants were followed from baseline procedure through hospital discharge, an expected average of less than 24 hours	Final post-procedural result of \<50% residual stenosis for all treated lesions for a participant during index procedure and without angiographic complications as determined by the Angiographic Core Laboratory.
Lesion Success of Endovascular PAD Treatment(s)	Participants were followed from baseline procedure through hospital discharge, an expected average of less than 24 hours	Final post-procedural result of \<50% residual stenosis for a given lesion treated during index procedure without angiographic complications as determined by the Angiographic Core Laboratory.
Rate of Freedom From Major Adverse Events (MAEs) at One (1) and Three (3) Years	One (1) year and three (3) years post-procedure	A Kaplan-Meier analysis was performed to determine the percent probability that the study participant was free from a major adverse event through 1 year and 3 years. 1- and 3-year MAE is composed of: * Death within 30 days of index procedure * Unplanned major (above the ankle) amputation of the target limb * Clinically-driven TVR (Target Vessel Revascularization) of the target limb

Secondary Outcome Measures

Name	Time	Method

Locations (52): Mercy Gilbert Medical Center
🇺🇸
Gilbert, Arizona, United States
Phoenix Heart Cardiovascular
🇺🇸
Glendale, Arizona, United States
St. Luke's Medical Center
🇺🇸
Phoenix, Arizona, United States
Arkansas Heart Hospital
🇺🇸
Little Rock, Arkansas, United States
Cedars-Sinai Heart Institute
🇺🇸
Los Angeles, California, United States
Denver Heart
🇺🇸
Denver, Colorado, United States
VA Eastern Colorado Healthcare System
🇺🇸
Denver, Colorado, United States
Colorado Heart and Vascular, PC
🇺🇸
Lakewood, Colorado, United States
Hartford Hospital
🇺🇸
Hartford, Connecticut, United States
Yale-New Haven Hospital
🇺🇸
New Haven, Connecticut, United States
Scroll for more (42 remaining)
Mercy Gilbert Medical Center
🇺🇸Gilbert, Arizona, United States